Minimally invasive pancreatic resections: cost and value perspectives

the Minimally Invasive Pancreatic Resection Organizing Committee

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Background The number of minimally invasive pancreatic resections (MIPR) performed for benign or malignant disease, have increased in recent years. However, there is limited information regarding cost/value implications. Methods An international conference evaluating MIPR was held during the 12th Bi-Annual International Hepato-Pancreato-Biliary Association (IHPBA) World Congress in Sao Paulo, Brazil, on April 20th, 2016. This manuscript summarizes the presentations that reviewed current topics in cost and value as they pertain to MIPR. Results Compared to the open approach, MIPR's are associated with higher operative costs but lower postoperative costs. However, measurements of patient value (defined as improvement in both quantity and quality of life) and financial value (using incremental cost-effectiveness ratio) are required to determine the true value at societal level. Conclusion Challenges remain as to how the potential benefits, both to the patient and the healthcare system as a whole, are measured. Research comparing MIPR versus other techniques for pancreatectomy will require appropriate and valid measurement tools, some of which are yet to be refined. Nonetheless, the experience to date would support the continued development of MIPR by experienced surgeons in high-volume pancreatic centers, married with appropriate review and recalibration.

Original languageEnglish (US)
Pages (from-to)225-233
Number of pages9
JournalHPB
Volume19
Issue number3
DOIs
StatePublished - Mar 1 2017
Externally publishedYes

Fingerprint

Costs and Cost Analysis
Pancreatectomy
Cost-Benefit Analysis
Brazil
Quality of Life
Delivery of Health Care
Research
Surgeons

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this

the Minimally Invasive Pancreatic Resection Organizing Committee (2017). Minimally invasive pancreatic resections: cost and value perspectives. HPB, 19(3), 225-233. https://doi.org/10.1016/j.hpb.2017.01.019

Minimally invasive pancreatic resections : cost and value perspectives. / the Minimally Invasive Pancreatic Resection Organizing Committee.

In: HPB, Vol. 19, No. 3, 01.03.2017, p. 225-233.

Research output: Contribution to journalArticle

the Minimally Invasive Pancreatic Resection Organizing Committee 2017, 'Minimally invasive pancreatic resections: cost and value perspectives', HPB, vol. 19, no. 3, pp. 225-233. https://doi.org/10.1016/j.hpb.2017.01.019
the Minimally Invasive Pancreatic Resection Organizing Committee. Minimally invasive pancreatic resections: cost and value perspectives. HPB. 2017 Mar 1;19(3):225-233. https://doi.org/10.1016/j.hpb.2017.01.019
the Minimally Invasive Pancreatic Resection Organizing Committee. / Minimally invasive pancreatic resections : cost and value perspectives. In: HPB. 2017 ; Vol. 19, No. 3. pp. 225-233.
@article{c00a357348b446e1aaa3a705769b8cb0,
title = "Minimally invasive pancreatic resections: cost and value perspectives",
abstract = "Background The number of minimally invasive pancreatic resections (MIPR) performed for benign or malignant disease, have increased in recent years. However, there is limited information regarding cost/value implications. Methods An international conference evaluating MIPR was held during the 12th Bi-Annual International Hepato-Pancreato-Biliary Association (IHPBA) World Congress in Sao Paulo, Brazil, on April 20th, 2016. This manuscript summarizes the presentations that reviewed current topics in cost and value as they pertain to MIPR. Results Compared to the open approach, MIPR's are associated with higher operative costs but lower postoperative costs. However, measurements of patient value (defined as improvement in both quantity and quality of life) and financial value (using incremental cost-effectiveness ratio) are required to determine the true value at societal level. Conclusion Challenges remain as to how the potential benefits, both to the patient and the healthcare system as a whole, are measured. Research comparing MIPR versus other techniques for pancreatectomy will require appropriate and valid measurement tools, some of which are yet to be refined. Nonetheless, the experience to date would support the continued development of MIPR by experienced surgeons in high-volume pancreatic centers, married with appropriate review and recalibration.",
author = "{the Minimally Invasive Pancreatic Resection Organizing Committee} and Conlon, {Kevin C.} and {de Rooij}, Thijs and {van Hilst}, Jony and {Abu Hidal}, Mohammad and Julie Fleshman and Mark Talamonti and Tsafrir Vanounou and Richard Garfinkle and Vic Velanovich and David Kooby and Vollmer, {Charles M.} and Asbun, {Horacio J.} and Jeffrey Barkun and Besselink, {Marc G.H.} and Ugo Boggi and Conlon, {Kevin C.P.} and Han, {Ho Seong} and Hansen, {Paul D.} and Kendrick, {Michael L.} and Kooby, {David A.} and Montagnini, {Andre L.} and C. Palanivelu and R{\o}sok, {B{\aa}rd I.} and Shrikhande, {Shailesh V.} and Go Wakabayashi and Herbert Zeh and Vollmer, {Charles M.}",
year = "2017",
month = "3",
day = "1",
doi = "10.1016/j.hpb.2017.01.019",
language = "English (US)",
volume = "19",
pages = "225--233",
journal = "HPB",
issn = "1365-182X",
publisher = "John Wiley and Sons Inc.",
number = "3",

}

TY - JOUR

T1 - Minimally invasive pancreatic resections

T2 - cost and value perspectives

AU - the Minimally Invasive Pancreatic Resection Organizing Committee

AU - Conlon, Kevin C.

AU - de Rooij, Thijs

AU - van Hilst, Jony

AU - Abu Hidal, Mohammad

AU - Fleshman, Julie

AU - Talamonti, Mark

AU - Vanounou, Tsafrir

AU - Garfinkle, Richard

AU - Velanovich, Vic

AU - Kooby, David

AU - Vollmer, Charles M.

AU - Asbun, Horacio J.

AU - Barkun, Jeffrey

AU - Besselink, Marc G.H.

AU - Boggi, Ugo

AU - Conlon, Kevin C.P.

AU - Han, Ho Seong

AU - Hansen, Paul D.

AU - Kendrick, Michael L.

AU - Kooby, David A.

AU - Montagnini, Andre L.

AU - Palanivelu, C.

AU - Røsok, Bård I.

AU - Shrikhande, Shailesh V.

AU - Wakabayashi, Go

AU - Zeh, Herbert

AU - Vollmer, Charles M.

PY - 2017/3/1

Y1 - 2017/3/1

N2 - Background The number of minimally invasive pancreatic resections (MIPR) performed for benign or malignant disease, have increased in recent years. However, there is limited information regarding cost/value implications. Methods An international conference evaluating MIPR was held during the 12th Bi-Annual International Hepato-Pancreato-Biliary Association (IHPBA) World Congress in Sao Paulo, Brazil, on April 20th, 2016. This manuscript summarizes the presentations that reviewed current topics in cost and value as they pertain to MIPR. Results Compared to the open approach, MIPR's are associated with higher operative costs but lower postoperative costs. However, measurements of patient value (defined as improvement in both quantity and quality of life) and financial value (using incremental cost-effectiveness ratio) are required to determine the true value at societal level. Conclusion Challenges remain as to how the potential benefits, both to the patient and the healthcare system as a whole, are measured. Research comparing MIPR versus other techniques for pancreatectomy will require appropriate and valid measurement tools, some of which are yet to be refined. Nonetheless, the experience to date would support the continued development of MIPR by experienced surgeons in high-volume pancreatic centers, married with appropriate review and recalibration.

AB - Background The number of minimally invasive pancreatic resections (MIPR) performed for benign or malignant disease, have increased in recent years. However, there is limited information regarding cost/value implications. Methods An international conference evaluating MIPR was held during the 12th Bi-Annual International Hepato-Pancreato-Biliary Association (IHPBA) World Congress in Sao Paulo, Brazil, on April 20th, 2016. This manuscript summarizes the presentations that reviewed current topics in cost and value as they pertain to MIPR. Results Compared to the open approach, MIPR's are associated with higher operative costs but lower postoperative costs. However, measurements of patient value (defined as improvement in both quantity and quality of life) and financial value (using incremental cost-effectiveness ratio) are required to determine the true value at societal level. Conclusion Challenges remain as to how the potential benefits, both to the patient and the healthcare system as a whole, are measured. Research comparing MIPR versus other techniques for pancreatectomy will require appropriate and valid measurement tools, some of which are yet to be refined. Nonetheless, the experience to date would support the continued development of MIPR by experienced surgeons in high-volume pancreatic centers, married with appropriate review and recalibration.

UR - http://www.scopus.com/inward/record.url?scp=85014149874&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85014149874&partnerID=8YFLogxK

U2 - 10.1016/j.hpb.2017.01.019

DO - 10.1016/j.hpb.2017.01.019

M3 - Article

C2 - 28268161

AN - SCOPUS:85014149874

VL - 19

SP - 225

EP - 233

JO - HPB

JF - HPB

SN - 1365-182X

IS - 3

ER -